FDA Approves Oral Combination of Decitabine and Cedazuridine Tablets with Venetoclax for Newly Diagnosed AML By Ogkologos - June 3, 2026 227 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Study ASTX727-07 Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Withdrawal of the Application to Change the EMA Marketing Authorisation for... December 2, 2022 27-Year-Old Fighting Stage IV Cancer Gets Hit By COVID-19 And Sepsis... May 29, 2020 Extended Anticoagulation with Reduced-Dose Non-inferior to Full-Dose Apixaban for the Prevention... April 29, 2025 Adding Capivasertib to Fulvestrant Results in Longer PFS in Patients with... June 5, 2023 Load more HOT NEWS Researchers Have Discovered How Fat Cells Fuel The Spread Of Breast... Dad Sings “Ave Maria” For His Daughter At Disney World ESMO and ASCO publish joint consensus statement on streamlining clinical research First Direct Comparison of Ibrutinib versus Acalabrutinib in Patients with Previously...
